Hyphens Pharma International eyes Catalist IPO

It lodged a preliminary offer document in the SGX.

Hyphens Pharma International is eyeing an initial public offering (IPO) in Singapore and a listing in the Singapore Exchange (SGX) Catalist board. It lodged a preliminary offer document and announced DBS Bank as its sponsor, underwriter, and placement agent.

Hyphens Pharma is a speciality pharmaceutical and consumer healthcare group with a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia, and the Philippines.

It sells speciality pharmaceuticals, a proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore, and medical hypermart and digital supplies.

The proceeds of the IPO will go to business expansion, construction of an integrated facility, and other corporate services.

Its subsidiary, Hyphens Singapore, has previously paid dividends of approximately $1m and $7m for 2016 and 2017 respectively.

It has its regional headquarters in Singapore, where most of its operations are based.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia